SIGA-246 to Treat Smallpox

NCT00303225 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

NIH

Sponsor class

Conditions

Vaccinia

Interventions

DRUG: Vaccine: SIGA-246

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)